Recalls You Should Be Aware Of—Week of July 15,2018

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week:

Win Opportunity Knocks Recalls Raw Ground Beef Products Due to Possible E. Coli O45, O102 and O145 Contamination

Win Opportunity Knocks, doing business as Ottomanelli Wholesale Meats Inc., a St. Petersburg, Fla. establishment, is recalling approximately 6,020 pounds of fresh and frozen, raw ground beef products that may be contaminated with Shiga toxin-producing E. coli (STEC) O45, O103 and O145, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

The fresh and frozen, raw ground beef products were produced from June 18, 2018 through July 11, 2018. The following products are subject to recall:

• 5-lb boxes of (20/4oz.) frozen, raw “Packers Plus Patties” with “Approved JUN 18 2018” through “Approved JUL 11 2018”
• 10-lb. boxes of (8-oz.) frozen, raw “Debren Foods Inc. BEEF PATTIES” with “Approved JUN 18 2018” through “Approved JUL 11 2018”
• 10-lb. boxes of (40/4-oz.) frozen, raw “Nu Vista Foods Group Inc. BEEF PATTIES” with “Approved JUN 18 2018” through “Approved JUL 11 2018”
• 10-lb. boxes of (40/4-oz, 30/5-oz, 28/6-oz) of frozen, raw “Ottomanelli Beef Patties” with “Approved JUN 18 2018” through “Approved JUL 11 2018”
• 10 lb. bulk bag of fresh raw “Beef Patty Mix Ottomanelli Wholesale Meats Inc.” with “Approved JUN 18 2018” through “Approved JUL 11 2018”

For more information, check out the official announcement.

Hy-Vee Grocery Stores Voluntarily Recalls Spring Pasta Salad Due to Potential Salmonella Contamination

Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling its Hy-Vee Spring Pasta Salad due to the potential that it may be contaminated with Salmonella. The potential for contamination was brought to Hy-Vee’s attention last night when approximately 20 illnesses in Minnesota, South Dakota, Nebraska and Iowa were potentially linked back to customers consuming the salad. The voluntary recall includes Hy-Vee Spring Pasta Salads in both 1 pound (16 oz.) and 3 pound (48 oz.) containers produced between June 1, 2018, and July 13, 2018, and available from the deli service case.

The pasta salad was distributed to all of Hy-Vee’s 244 grocery stores across its eight-state region of Iowa, Illinois, Missouri, Kansas, Nebraska, South Dakota, Minnesota and Wisconsin. The product comes in a plastic container with a plastic lid. The expiration date range is between June 22, 2018, and Aug. 3, 2018. The expiration date can be found on the side of the container.

For the most recent case counts associated with the Multistate Outbreak of Salmonella Sandiego Linked to Pasta Salad, check out the Contagion® Outbreak Monitor.

For more information, read the official recall.

3 Recalls Issued for Valsartan For Treatment of Hypertension and Heart Failure Due to Contamination with Nitrosodimethylamine

Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., is voluntarily recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the consumer level.

As a precautionary measure, the distribution firm, Major Pharmaceuticals, is issuing a nationwide voluntary recall of all lots within expiry of Valsartan which were supplied by Teva Pharmaceuticals and labeled as Major Pharmaceuticals.

Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical. The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.

For more information on all recalls associated with Valsartan, check out the FDA’s news release.